Valuation: Roche Holding AG

Capitalization 266B 330B 284B 248B 458B 29,738B 498B 3,112B 1,202B 14,045B 1,240B 1,214B 51,355B P/E ratio 2025 *
18x
P/E ratio 2026 * 16.5x
Enterprise value 279B 347B 298B 260B 481B 31,224B 523B 3,268B 1,262B 14,747B 1,302B 1,274B 53,920B EV / Sales 2025 *
4.54x
EV / Sales 2026 * 4.34x
Free-Float
87.84%
Yield 2025 *
3.18%
Yield 2026 * 3.24%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.26%
1 week+1.14%
Current month+1.14%
1 month+17.28%
3 months+13.38%
6 months+16.14%
Current year+21.68%
More quotes
1 week 303
Extreme 303
319
1 month 264.2
Extreme 264.2
319
Current year 231.9
Extreme 231.9
319
1 year 231.9
Extreme 231.9
319
3 years 212.9
Extreme 212.9
319
5 years 212.9
Extreme 212.9
404.2
10 years 206.35
Extreme 206.35
404.2
More quotes
Manager TitleAgeSince
Chief Executive Officer 50 2023-03-14
Director of Finance/CFO 58 2011-06-05
Chief Tech/Sci/R&D Officer 58 2025-02-09
Director TitleAgeSince
Director/Board Member 67 1995-12-31
Chairman 58 2023-03-14
Director/Board Member 72 2015-03-02
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.26%+1.14%+21.30%+0.44% 330B
-0.41%-6.06%+22.37%+173.58% 905B
-0.27%-2.41%+35.05%+12.95% 487B
-1.15%-0.71%+28.33%+37.90% 400B
+0.58%-2.73%+28.01%+20.71% 281B
+0.19%+2.49%+18.48%+24.80% 255B
-1.16%-4.87%-3.70%-9.35% 248B
+1.24%-2.33%-59.84%-31.25% 214B
-3.02%-4.51%+20.25%+15.79% 178B
-1.14%-3.67%+29.80%+37.78% 150B
Average -0.30%-2.37%+14.01%+28.34% 344.69B
Weighted average by Cap. -0.13%-2.83%+18.15%+55.19%
See all sector performances

Financials

2025 *2026 *
Net sales 61.58B 76.48B 65.74B 57.4B 106B 6,883B 115B 720B 278B 3,251B 287B 281B 11,886B 63.13B 78.4B 67.39B 58.84B 109B 7,056B 118B 738B 285B 3,332B 294B 288B 12,185B
Net income 13.13B 16.31B 14.02B 12.24B 22.61B 1,468B 24.59B 154B 59.31B 693B 61.21B 59.91B 2,535B 14.55B 18.07B 15.53B 13.56B 25.04B 1,626B 27.24B 170B 65.7B 768B 67.8B 66.36B 2,808B
Net Debt 13.29B 16.5B 14.19B 12.39B 22.88B 1,485B 24.89B 155B 60.02B 701B 61.94B 60.62B 2,565B 8.15B 10.13B 8.7B 7.6B 14.04B 911B 15.27B 95.37B 36.82B 430B 38B 37.19B 1,574B
More financial data * Estimated data
Logo Roche Holding AG
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Employees
103,249
More about the company
Date Price Change Volume
25-12-05 310.90 CHF +0.26% 937,693
25-12-04 310.10 CHF -1.18% 1,018,755
25-12-03 313.80 CHF +0.16% 1,192,175
25-12-02 313.30 CHF +1.39% 1,052,632
25-12-01 309.00 CHF +0.52% 1,147,326

Delayed Quote Swiss Exchange, December 05, 2025 at 11:30 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
310.90CHF
Average target price
311.78CHF
Spread / Average Target
+0.28%
Consensus

Quarterly revenue - Rate of surprise